Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin

Date
2019-12-01
Authors
Celik, Haydar
Wakim, Paul
Pritchard, William F
Castro, Meryll
Leonard, Shelby
Karanian, John W
Dewhirst, Mark W
Lencioni, Riccardo
Wood, Bradford J
Show More
(9 total)
Repository Usage Stats
57
views
33
downloads
Type
Journal article
Subject
Science & Technology
Life Sciences & Biomedicine
Radiology, Nuclear Medicine & Medical Imaging
Peripheral Vascular Disease
Cardiovascular System & Cardiology
COAGULATION
METASTASES
HEAT
SIZE
Permalink
https://hdl.handle.net/10161/20611
Published Version (Please cite this version)
10.1016/i.jvir.2019.04.023
Publication Info
Celik, Haydar; Wakim, Paul; Pritchard, William F; Castro, Meryll; Leonard, Shelby; Karanian, John W; ... Wood, Bradford J (2019). Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 30(12). pp. 1908-1914. 10.1016/i.jvir.2019.04.023. Retrieved from https://hdl.handle.net/10161/20611.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item record

Scholars@Duke

Dewhirst

Mark Wesley Dewhirst

Gustavo S. Montana Distinguished Professor Emeritus of Radiation Oncology
Mark W. Dewhirst, DVM, PhD is the Gustavo S. Montana Professor of Radiation Oncology and Vice Director for Basic Science in the Duke Cancer Institute. Dr. Dewhirst has research interests in tumor hypoxia, angiogenesis, hyperthermia and drug transport. He has spent 30 years studying causes of tumor hypoxia and the use of hyperthermia to treat cancer. In collaboration with Professor David Needham in the Pratt School of Engineering, he has developed a novel thermally sensitive drug carrying liposom
Open Access

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy

Rights for Collection: Scholarly Articles

Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info